Updates in antifungal susceptibility testing of filamentous fungi |
| |
Authors: | Ana Espinel-Ingroff Emilia Canton Javier Peman |
| |
Affiliation: | (1) Virginia Commonwealth University Medical Center, 3804 Dover Road, Richmond, VA 23221, USA |
| |
Abstract: | The Clinical and Laboratory Standards Institute (CLSI) has standardized broth microdilution and disk diffusion methodology for testing filamentous fungi (molds) that cause invasive disease. Quality control MIC (minimal inhibitory concentration) and MEC (minimal effective concentration; echinocandins only) limits are also available in the recently published CLSI M38-A2 document. Although breakpoints based on correlations of in vitro results and clinical outcome have not been established, MIC or MEC and zone diameter categories for five antifungal agents and various mold species, as well as epidemiologic cutoffs for Aspergillus fumigatus versus the triazoles, have been recently documented. Some insights of the potential clinical value of reference methods also have been reported. During the past few years, the potential utility of various commercial methods has been evaluated by comparing them with reference methodology. This review summarizes and discusses the advantages and disadvantages of these developments. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|